You have 9 free searches left this month | for more free features.

MDS

Showing 1 - 25 of 3,289

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AML/MDS, Acute Myeloid Leukemia, MDS Trial (Danvatirsen, Danvatirsen + Venetoclax)

Not yet recruiting
  • AML/MDS
  • +2 more
  • (no location specified)
Aug 14, 2023

MDS, Myeloproliferative Tumor, Anemia Trial in Tampa (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Tampa, Florida
    Moffitt Cancer Center
Feb 16, 2023

MDS Trial (Roxadustat in combination with retinoic acid)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Roxadustat in combination with retinoic acid
  • (no location specified)
Aug 26, 2023

Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML) Trial in Seoul

Active, not recruiting
  • Patients With MDS, Acute Myeloid Leukemia (AML) Evolving From MDS, and Chronic Myelomonocytic Leukemia (CMML)
  • Seoul, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023

MDS Trial in Houston (Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Houston, Texas
    M D Anderson Cancer Center
Nov 2, 2023

MDS Trial in Beijing (Lenalidomide, Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 16, 2023

Cancer, MDS-EB, MDS Trial in Athens, Southampton, Sheffield (INKmune)

Recruiting
  • Cancer
  • +4 more
  • INKmune
  • Athens, Attiki, Greece
  • +2 more
Jul 3, 2023

MDS Trial in Beijing (Roxadustat, Luspatercept)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Beijing, China
    Peking union medical college hospital
Aug 17, 2023

Lower-risk Myelodysplastic Syndrome Trial in Tampa (JSP191)

Recruiting
  • Lower-risk Myelodysplastic Syndrome
  • Tampa, Florida
    Moffitt Cancer Center
Jun 20, 2023

MDS, Myelodysplastic Anemia, Myelodysplastic Syndrome With Isolated Del(5Q) Trial (description of MDS pzatient cohort)

Recruiting
  • Myelodysplastic Syndromes
  • +5 more
  • description of MDS pzatient cohort
  • Brest, France
    Chu Brest
Oct 27, 2022

MDS, Chronic Myelomonocytic Leukemia Trial in Tianjin (BC3402, Azacitidine)

Recruiting
  • Myelodysplastic Syndromes
  • Chronic Myelomonocytic Leukemia
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital, Chinese Acade
Jul 30, 2023

MDS/MPN Trial in Nanjing (Azacitidine (AZA) with Ruxolitinib)

Recruiting
  • MDS/MPN
  • Azacitidine (AZA) with Ruxolitinib
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital of Nanjing Medical University
Apr 17, 2023

Lower-risk MDS Patients

Recruiting
  • MDS
    • Leipzig, Germany
      University Hospital Leipzig
    Oct 13, 2022

    Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R Trial in Canada, United States (Etavopivat)

    Recruiting
    • Very Low Risk, Low Risk, or Intermediate Risk MDS Per IPSS-R
    • Ocala, Florida
    • +3 more
    Jan 30, 2023

    Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial run

    Recruiting
    • Severe Aplastic Anemia (SAA)
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 28, 2023

    AML, MDS Trial in Tianjin (XZB-0004)

    Not yet recruiting
    • AML
    • MDS
    • Tianjin, Tianjin, China
      Hematology Hospital, Chinese Academy of Medical Sciences
    Feb 13, 2023

    Refractory MDS Patients

    Active, not recruiting
    • Myelodysplastic Syndromes
      • Stanford, California
        Stanford MDS Center
      Aug 1, 2022

      Acute Myeloid Leukemia, Myelodysplastic Tumor Trial (Magrolimab, 7+3, CPX-351)

      Not yet recruiting
      • Acute Myeloid Leukemia
      • Myelodysplastic Neoplasm
      • (no location specified)
      Apr 24, 2023

      MDS, MDS, Thrombocytopenia Trial (Placebo, Romiplostim)

      Completed
      • MDS
      • +2 more
      • Placebo
      • Romiplostim
      • (no location specified)
      Nov 4, 2022

      MDS Over Time - Comparison of Treated vs Untreated Patients

      Completed
      • Myelodysplastic Syndromes
        • Vienna, Austria
          Hanusch Krankenhaus, 3.Medizinische Abteilung
        Nov 21, 2022

        Immunophenotyping of Blast Cells and Immune Effector Cells in

        Completed
        • Leukemia
        • Blood and Marrow sample
        • Marseille, France
          Assistance Publique - Hopitaux de Marseille
        Jan 23, 2023

        MDS Trial (Decitabine/Cedazuridine, Magrolimab)

        Not yet recruiting
        • Myelodysplastic Syndromes
        • (no location specified)
        Apr 18, 2023

        MDS, AML Trial in Bronx (Venetoclax, Decitabine)

        Recruiting
        • MDS
        • AML
        • Bronx, New York
          Montefiore Medical Center
        Jul 22, 2022

        AML, MDS Trial in Houston (Vibecotamab, Dexamethasone, Acetaminophen)

        Recruiting
        • AML
        • MDS
        • Houston, Texas
          M D Anderson Cancer Center
        Sep 29, 2022

        Hematologic Malignancy Trial in Guangzhou (BC3402 Injection)

        Not yet recruiting
        • Hematologic Malignancy
        • BC3402 Injection
        • Guangzhou, Guangdong, China
          The First Affiliated Hospital of Jinan University
        Jan 10, 2023